Article

Localized Diffuse Melanosis Associated With Melanoma Successfully Treated With Imiquimod Cream 5%: A Case Report and Review of the Literature

Author and Disclosure Information

Diffuse melanosis associated with melanoma is a rare condition characterized by rapidly acquired skin pigmentation that usually occurs in the setting of advanced metastatic melanoma. We report a case of localized diffuse melanosis associated with melanoma on the lower left leg that successfully responded to treatment with imiquimod cream 5%. Initial treatment included application of imiquimod from the knee to the ankle once daily. Application frequency was increased to up to 3 times daily and eventually was switched to overnight occlusion until complete clearance was achieved.

This rare condition is not completely understood, as only approximately 20% of cases have shown individual melanoma metastases within the pigmented skin. In our patient, as in the majority of cases, we were unable to detect individual metastases within the pigmented skin. This case is unique because diffuse melanosis was confined to an extremity. The clearing of the pigmented skin was impressive. Imiquimod may have activity against melanoma, melanoma in situ, and diffuse melanosis associated with melanoma, as demonstrated in our case.


 

Recommended Reading

Skin cancer risk stands out in anti-TNF biologics use
MDedge Dermatology
Product News: 02 2014
MDedge Dermatology
Cosmetic Corner: Dermatologists Weigh in on Sunless Tanners
MDedge Dermatology
Final results validate sentinel-node biopsy for melanoma
MDedge Dermatology
Ingenol mebutate improves outcomes in actinic keratosis
MDedge Dermatology
Youth tanning curbed in states with restrictions
MDedge Dermatology
Video intervention inspires men to undergo skin exams
MDedge Dermatology
Aggressive secondary squamous carcinoma appeared during BRAF inhibitor targeted therapy
MDedge Dermatology
Counterphobia and Poor Sun Protection Practices in First-Degree Relatives of Melanoma Patients
MDedge Dermatology
Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma
MDedge Dermatology